Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SARMs Subject To Steroids Scheduling By DEA Under Hatch, Whitehouse Bill

Executive Summary

The Utah Republican and Rhode Island Democrat sponsor legislation to make selective androgen receptor modulators subject to the same authority the Drug Enforcement Administration has to regulate anabolic steroids. Hatch said the SARMs Control Act of 2018 would "ensure that the DEA has the authority it needs to prevent abuse and diversion of these dangerous substances.”

Advertisement

Related Content

Health, Beauty And Wellness News: FTC, ADM, Hain, CRN, Boston Therapeutics
Massachusetts Bid Stalls To Age-Restrict Sales Of Bodybuilding, Weight Loss Supplements
Health, Beauty And Wellness News: GNC, Vitamin Shoppe, NPA, AHPA
Hatch Closing Act: OTC Monograph Reform Legislation?
CDB Supplements Next On FDA's Investigational New Drug Warning List
Industry News Roundup

Topics

Advertisement
UsernamePublicRestriction

Register

RS121587

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel